| Calluna Pharma AS. (10/9/24). "Press Release: Calluna Pharma Appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board". Oslo & Boston, MA. |
2024-10-09 |
| Valneva S.E.. (7/22/24). "Press Release: CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine". Oslo & Saint-Herblain. |
2024-07-22 |
| BioNTech SE. (5/29/24). "Press Release: BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem". Mainz & Oslo. |
2024-05-29 |
| Circio Holding ASA. (10/10/23). "Press Release: Circio and Neoregen Biotech Enter Collaboration for Delivery of Novel Circular RNA Therapeutics Using NICT technology". |
2023-10-10 |
| CEPI. (8/29/23). "Press Release: CEPI and University of Oxford to Accelerate Vaccine Development against Disease X". Oslo & Oxford. |
2023-08-29 |
| Targovax ASA. (4/19/23). "Press Release: Targovax to Rebrand as Circio, an Innovator in Next Generation Circular RNA Therapeutics". |
2023-04-19 |
| Targovax ASA. (2/16/23). "Press Release: Targovax Announces Financing of up to NOK 300m Over Three Years to Advance Its Clinical Cancer Programs and Pre-clinical Circular RNA platform". Oslo. |
2023-02-16 |
| Nykode Therapeutics A/S. (12/19/22). "Press Release: Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership". Oslo. |
2022-12-19 |
| Hemispherian AS. (11/24/22). "Press Release: Hemispherian Raises the First Tranche of a Series A to Fund the Development of Its Novel Cancer Therapeutics". Oslo. |
2022-11-24 |
| Hemispherian AS. (10/19/22). "Press Release: Hemispherian Secures EUR 10M in Financing from the European Innovation Council (EIC) Accelerator Program". Oslo. |
2022-10-19 |
| AH Diagnostics A/S. (9/1/22). "Press Release: AH Diagnostics AS Acquires DiuVita Diagnostics AS". |
2022-09-01 |
| Nordic Nanovector ASA. (7/5/22). "Press Release: Nordic Nanovector to Discontinue PARADIGME, Its Phase 2b Trial with Betalutin in 3L R and R Follicular Lymphoma". Oslo. |
2022-07-05 |
| Sidekick Health. (5/5/22). "Press Release: Sidekick Raises $55M Series B to Drive Further Growth". Berlin, Boston & Reykjavik. |
2022-05-05 |
| Hemispherian AS. (5/3/22). "Press Release: Hemispherian Raises Seed Funding for Novel Cancer Therapeutics". Oslo. |
2022-05-03 |
| Vaximm AG. (3/8/22). "Press Release: NEC OncoImmunity Acquires Vaximm’s Neoantigen Vaccine Development Assets". Oslo, Tokyo, Basel & Mannheim. |
2022-03-08 |
| Targovax ASA. (2/28/22). "Press Release: Targovax ASA Strengthens Management with Lubor Gaal as Chief Financial Officer". Oslo. |
2022-02-28 |
| Cytovation AS. (1/25/22). "Press Release: Cytovation Raises $20 Million in Series A Financing Round to Advance Clinical Development of CyPep-1, a First-in-Class Targeted Tumor Membrane Immunotherapy". Bergen. |
2022-01-25 |
| Nykode Therapeutics A/S. (11/23/21). "Press Release: Nykode Therapeutics (formerly Vaccibody*)) Enters into Multi-target License and Collaboration Agreement with Regeneron to Develop Innovative Vaccines against Cancer and Infectious Diseases". Oslo. |
2021-11-23 |
| Targovax ASA. (10/20/21). "Press Release: Targovax ASA Appoints Dr. Erik Digman Wiklund as New CEO". Oslo. |
2021-10-20 |
| Genetic Analysis AS. (10/5/21). "Press Release: Microbiome Dx Genetic Analysis Raises USD 6.8 M in IPO". Oslo. |
2021-10-05 |
| Hadean Ventures. (9/27/21). "Press Release: Hadean Ventures Announces the 1st Closing of EUR 90m for Its Second Fund". Oslo. |
2021-09-27 |
| Nordic Nanovector ASA. (9/14/21). "Press Release: Nordic Nanovector Appoints Experienced Pharmaceutical Business Leader Erik Skullerud as Chief Executive Officer". Oslo. |
2021-09-14 |
| Zelluna Immunotherapy AS. (8/19/21). "Press Release: Exclusive License Agreement with the U.S. National Cancer Institute to Develop and Commercialize KK-LC-1 Targeting Allogeneic »Off-the-Shelf« TCR Based Natural Killer (TCR-NK) Cell Therapies". Oslo. |
2021-08-19 |
| LifeSci Advisors, LLC. (6/21/21). "Press Release: LifeSci Advisors Nordic Biotech Summit". |
2021-06-21 |
| Link Medical Research AS. (4/14/21). "Press Release: Link Medical Strengthens Its Position in Germany as a Strategic Gateway between Europe and the Nordics". Berlin. |
2021-04-14 |
| Step Pharma SAS. (3/24/21). "Press Release: Step Pharma Raises EUR35 Million in Series B Financing to Advance First in Class CTPS1 inhibitor into the Clinic in T Cell Malignancies". Archamps. |
2021-03-24 |
| Nordic Nanovector ASA. (3/18/21). "Press Release: Nordic Nanovector Appoints Experienced Pharmaceutical Company Leader Peter L. Braun as Chief Executive Officer". Potsdam & Berlin. |
2021-03-18 |
| Targovax ASA. (3/7/22). "Press Release: Targovax ASA and Agenus Announce Collaboration on Mutant KRAS Cancer Vaccine Adjuvanted with QS-21 STIMULON". Oslo. |
2021-03-07 |
| Nordic Nanovector ASA. (2/25/21). "Press Release: Nordic Nanovector ASA – Share Capital Increase Registered". Oslo. |
2021-02-25 |
| Nordic Nanovector ASA. (2/23/21). "Press Release: Nordic Nanovector Launches a Private Placement of New Shares[Not for US, CA, JP or AU]". Oslo. |
2021-02-23 |
| Nordic Nanovector ASA. (2/23/21). "Press Release: Nordic Nanovector – Private Placement Successfully Completed [Not for US, CA, JP or AU]". Oslo. |
2021-02-23 |
| Exact Therapeutics AS. (1/29/21). "Press Release: Exact Therapeutics Announces Change of CFO with Departure of Stig Jarle Pettersen at the End of His Contracted Period". Oslo & London. |
2021-01-29 |
| Exact Therapeutics AS. (1/26/21). "Press Release: Exact Therapeutics Announces Appointment of Dr Hilary McElwaine-Johnn as Chief Medical Officer and Opening of London Office". Oslo & London. |
2021-01-26 |
| NuCana plc. (12/21/20). "Press Release: NuCana Appoints Andrew Kay as Board Chairman". Edinburgh. |
2020-12-21 |
| Sidekick Health. (10/28/20). "Press Release: Sidekick Raises $20M in Series A Funding Round Led by Wellington and Asabys". Barcelona, Munic & Reykjavik. |
2020-10-28 |
| Vaccibody AS. (10/1/20). "Press Release: Vaccibody Enters into Worldwide License and Collaboration Agreement with Genentech, a Member of the Roche Group, to Develop Individualized Neoantigen Cancer Vaccines". Oslo. |
2020-10-01 |
| Nordic Nanovector ASA. (9/23/20). "Press Release: Nordic Nanovector – Private Placement Successfully Completed [Not for US, CA, JP or AU]". Oslo. |
2020-09-23 |
| Gesynta Pharma AB. (7/7/20). "Press Release: Gesynta Raises SEK 190 Million in Round Led by Hadean Ventures to Accelerate Development of First-in-class mPGES-1 Inhibitor GS-248 for Systemic Sclerosis". Stockholm. |
2020-07-07 |
| Zelluna Immunotherapy AS. (6/11/20). "Press Release: Zelluna Immunotherapy Raises Funds to Fully Focus on Developing Allogeneic “Off-the-Shelf” TCR based Natural Killer (TCR-NK) Cell Therapies". Oslo. |
2020-06-11 |
| Oncoinvent AS. (6/11/20). "Press Release: Oncoinvent Announces Dosing of First Patient with Radspherin in a Second Phase 1 Clinical Trial". Oslo. |
2020-06-11 |
| Exact Therapeutics AS. (6/3/20). "Press Release: Norwegian Exact Therapeutics Appoints Dr. Rafiq Hasan as CEO". |
2020-06-03 |
| Aqilion AB. (5/11/20). "Press Release: Torgeir Vaage Joins Aqilion as Chief Financial Officer". Helsingborg. |
2020-05-11 |
| Neuro Event Labs Oy. (4/8/20). "Press Release: Neuro Event Labs Closes €3.9M Series A Round to Become the Standard for Epilepsy Diagnostics". |
2020-04-08 |
| Fluidigm Corporation. (2/26/20). "Press Release: Fluidigm Completes Acquisition of InstruNor AS". South San Francisco, CA. |
2020-02-26 |
| CureVac AG. (1/31/20). "Press Release: CureVac and CEPI Extend Their Cooperation to Develop a Vaccine against Coronavirus nCoV-2019". Tübingen & Boston, MA & Oslo. |
2020-01-31 |
| Bone Therapeutics S.A.. (12/19/19). "Press Release: Bone Therapeutics Announces the Appointment of Dr. Miguel Forte as CEO to Lead the Company into the Next Phase of Development". Gosselies. |
2019-12-19 |
| Zelluna Immunotherapy AS. (12/19/19). "Press Release: Zelluna Immunotherapy Appoints Namir Hassan as Chief Executive Officer". Oslo. |
2019-12-19 |
| Sidekick Health. (12/16/19). "Press Release: Sidekick Partners with Bayer to Provide Digital Therapy Expansion for PAD Patients". |
2019-12-16 |
| Novo Holdings A/S. (11/26/19). "Press Release: Novo Seeds Expands Company Formation Activities at BiOrigin with Seasoned Entrepreneurs". Copenhagen. |
2019-11-26 |
| Zelluna Immunotherapy AS. (11/19/19). "Press Release: Zelluna Immunotherapy and Glycostem Therapeutics Announce Partnership to Develop Allogeneic TCR-NK Therapies". Oslo & Oss. |
2019-11-19 |
| Zelluna Immunotherapy AS. (11/4/19). "Press Release: Zelluna Immunotherapy Appoints Dr Bent Jakobsen, a Pioneer of TCR Therapeutics, to the Board of Directors". Oslo. |
2019-11-04 |
| Evaxion Biotech A/S. (10/30/19). "Press Release: Glenn S. Vraniak Joins Evaxion as CFO". Copenhagen. |
2019-10-30 |
| Themis Bioscience GmbH. (10/29/19). "Press Release: Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine". Vienna & Oslo. |
2019-10-29 |
| Lytix Biopharma AS. (9/12/19). "Press Release: Lytix Biopharma AS Appoints Øystein Rekdal as the new CEO". |
2019-09-12 |
| OncoImmunity AS. (7/29/19). "Press Release: NEC and OncoImmunity AS Combine Forces to Use AI to Empower Personalized Cancer Immunotherapy". |
2019-07-29 |
| NEC Corporation. (7/29/19). "Press Release: NEC Acquires Norwegian Bioinformatics Company, OncoImmunity AS". Tokyo. |
2019-07-29 |
| Photocure ASA. (7/1/19). "Press Release: Photocure and Asieris Enter into a Global Licensing Deal for Cevira with up to USD 250 Million in Milestones and Double-digit Royalties". Oslo. |
2019-07-01 |
| Zelluna Immunotherapy AS. (6/25/19). "Press Release: Zelluna Immunotherapy Appoints Jens-Peter Marschner as Chief Medical Officer". Oslo. |
2019-06-25 |
| Saga Diagnostics AB. (6/11/19). "Press Release: Saga Raises 40 Million SEK (€3.7 Million) to Advance Ultrasensitive Cancer Liquid Biopsies". Lund & Oslo. |
2019-06-11 |
| Themis Bioscience GmbH. (6/4/19). "Press Release: CEPI Awards up to US$21 Million to Themis Bioscience for Phase 3 Chikungunya Vaccine Development". Vienna & Oslo. |
2019-06-04 |
| CureVac AG. (2/27/19). "Press Release: CEPI Awards US$ 34m Contract to CureVac to Advance the RNA Printer—a Disruptive, Transportable mRNA Vaccine Manufacturing Platform that Can Rapidly Combat Multiple Diseases". Oslo. |
2019-02-27 |
![[LSS] Life-Sciences-Scandinavia.com - The Scandinavian Life Sciences Web Portal](/images/basics/lss-life-sciences-scandinavia-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
